Neurosense Therapeutics Ltd. NRSN
NASDAQ · United States · Health Technology
$4.05-0.38 (-8.58%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q1 2026 | 2026-09-25 | -2.06 | -3.90 | +47.2% | $0 | — | -31.1%$7.40→$5.10 |
| Q2 2026 | 2026-09-25 | -2.06 | -3.90 | +47.2% | $0 | — | -31.1%$7.40→$5.10 |
| Q4 2024 | 2025-04-07 | -1.20 | -3.00 | +60.0% | — | — | — |
| Q3 2024 | 2024-12-18 | -2.20 | -2.20 | 0.0% | — | — | — |
| Q2 2024 | 2024-09-30 | -0.40 | -3.60 | +88.9% | — | — | — |
| Q1 2024 | 2024-06-24 | -7.00 | -4.10 | -70.7% | — | — | — |
| Q4 2023 | 2024-04-05 | -3.20 | -4.00 | +20.0% | — | — | — |
| Q3 2023 | 2023-11-28 | 2.00 | -5.20 | +138.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.